Skip navigation
TUFTS CTSI WORKSPACE
Log in for access to resources and a secure project workspace. Register LOGIN

Comparative Effectiveness Research (CER) Survey Course

CER Course Outline and Lecture Titles

The live in-person course will take place at:
Tufts University Sackler School of Graduate Biomedical Sciences
145 Harrison Avenue
Boston, Massachusetts  02111
For directions, please click here

Lectures are also now available online at I LEARN.

Room assignments will vary and are indicated below.

Week/Date

Unit and Title of Presentation Presenter(s)

Room Assignment

1
Feb 1

Unit 1: Introduction
Comparative Effectiveness Research: Recent History & Role in Healthcare
Rationale for CER

 

Harry P. Selker, MD, MSPH
Peter J. Neumann, ScD

114 West


Feb 8

A Review of Evidence-Based Medicine (EBM) and a Framework for Understanding the CER Agenda (evidence generation, synthesis, integration and decision making) Thomas W. Concannon, PhD 114 West
       

3
Feb 15

Unit 2: Evidence Generation
Comparative Effectiveness Trials and Other Prospective Comparative Effectiveness Studies
Integrating Genetic Information into Clinical Effectiveness Trials

 

David M. Kent, MD, MSc


Thomas A. Trikalinos, MD, PhD

114 West

4
Feb 22

Personalized Medicine, Heterogeneity of Treatment Effect and Implications for Comparative Effectiveness David M. Kent, MD, MSc 114 West

March 1
Retrospective and Observational Comparative Effectiveness Studies Dana Gelb Safran, ScD 
Peter K. Lindenauer, MD, MSc
First Floor Lecture Hall
       


March 8

Unit 3: Evidence Synthesis 
Systematic Review and Meta-Analysis
Joseph Lau, MD 
Christopher H. Schmid, PhD

114 West

       


March 15

Unit 4: Evidence Integration 
Decision modeling - Cost Effectiveness
John B. Wong, MD 
Stephen G. Pauker, MD
812


March 22

Decision modeling - Simulations Joshua T. Cohen, PhD 114 West
       


March 29

Unit 5: Use of Evidence in Decision Making 
Community Engagement and Input into CER

Laurel K. Leslie, MD, MPH

114 West

10 
April 5

Clinical Practice Guidelines Katrin Uhlig, MD, MS 114 West

11 
April 12

Clinical Effectiveness Trials and Predictive Instruments as Decision Support for Implementing CER Harry P. Selker, MD, MSPH 216 A
April 19 No Class

12 
April 26

Drug Development in the CER Era Kenneth I. Kaitin, PhD 516

13
May 3

Using Comparative Effectiveness Research to Reach Employers and Employees Debra J. Lerner, MS, PhD 114 West

14
May 10

Economic and Policy Implications of CER Christopher P. Tompkins, PhD 114 West
       

15
May 17

Unit 6: Future Directions in CER
The IOM 100 Priorities and AHRQ 14 Priority Conditions and Populations
Thomas W. Concannon, PhD and Faculty panel 114 West